Respiratory Diagnostics Market worth $8.2 billion by 2029 - Exclusive Report by MarketsandMarkets™

 As per the recently published report by MarketsandMarket™, The report "Respiratory Diagnostics Market by Product & Services (Devices, Reagents, Software), Test (PFT, Peak Flow, Spirometry), OSA, Imaging (X-ray, CT, MRI, PET), Molecular (PCR, DNA Sequencing), Indication (Lung Cancer, Asthma, COPD, TB) - Global Forecast to 2029".

The report Respiratory Diagnostics Market is expected to reach USD 8.2 billion by 2029 from USD 5.6 billion in 2023, at a CAGR of 6.6%, during the forecast period.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459
 
Browse

• 83       Market Data Tables
• 45       Figures
• 146     Pages and in-depth TOC on "Respiratory Diagnostics Market - Global Forecast to 2029”

Some of the prominent key players are:

• Koninklijke Philips N.V. (Netherlands),
• BD (US),
• Abbott (US),
• Thermo Fisher Scientific Inc. (US),
• GE HealthCare (US),
• Bio-Rad Laboratories, Inc. (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Respiratory Diagnostics Market.

• The growing trend towards point-of-care testing (POCT) represents a paradigm shift in healthcare, significantly contributing to the growth of the instruments and devices segment. Portable respiratory diagnostic instruments, such as handheld spirometers, peak flow meters, and portable imaging devices, enable real-time assessment of lung function and conditions.
• The escalating prevalence of respiratory disorders, particularly chronic obstructive pulmonary disease (COPD) and asthma, underscores the critical role of mechanical tests in assessing lung function. Mechanical tests, such as spirometry and peak flow tests, play a fundamental role in evaluating lung function by measuring parameters like airflow, lung volume, and capacity.
• Personalized asthma care is increasingly reliant on sophisticated diagnostic tools that consider individual patient profiles. Advanced diagnostics, such as molecular testing and biomarker analysis, enable healthcare professionals to delve into the specific genetic and molecular factors contributing to a patient's asthma.
• Hospitals and clinics are increasingly integrating respiratory diagnostics into routine care protocols. The seamless integration of respiratory diagnostics within hospitals and clinics ensures that diagnostic services are readily accessible to a broad spectrum of patients seeking routine or specialized care.
• In 2022, North America held the largest market share for respiratory diagnostics market. The growing awareness of the significance of early detection and effective management of respiratory diseases has emerged as a significant factor propelling the utilization of respiratory diagnostics products and services in North America.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=163390459

 

Growth in this market is largely driven by the growth in the large patient population suffering from pulmonary diseases, increase in pre-term deliveries, rise in adults being exposed to poor air quality index environment, increased smoking of tobacco, increased cases of passive smoking due to exposure to harmful smoke inhalations, rise in dust and allergies associated with it leading to asthma and COPD, rising R&D expenditure by leaders in this market, increased trend of smoking in women more than men, and massive rise in underlying lung diseases, and continuous exposre to indoor or outdoor dust, making it prone to infections, leading the market growth.

 

 

 

Hollow Fiber Filtration Market: Future Growth in the biopharmaceutical industry

 The growth of the global Hollow Fiber Filtration Market is driven by factors such as the rising preference for continuous manufacturing, increasing use of single use technologies, and the rising biopharmaceutical industry. In addition, emerging economies, and increased investment cell-based research are expected to provide significant growth opportunities for players in the market.

The global Hollow fiber filtration market is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039

Market Segmentation:

Based on material, the market is segmented into polymeric and ceramic. The polymeric segment is further sub segmented into PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020, PS/PES membrane filters accounted for the largest market share as they are designed to eliminate particulates during standard filtration. They have low protein and drug binding characteristics and are stable at alkaline pH. PS/PES membranes are recommended for aqueous applications and for biological samples.

Based on application type, the market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2020, continuous cell perfusion accounted for the largest market share due to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing.

Regional Analysis:

The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to innovation, a giant talent pool of scientists, low labor, and manufacturing costs. The region has also witnessed mass production because of technology and a rise in continuous manufacturing instead of batch production in the previous era.

Recent Developments

• In 2020, Sartorius Stedim Biotech (France) acquired WaterSep BioSeparations to expand its product offerings in the market.
• In 2020, Repligen Corporation (US) acquired ARTeSYN Biosolutions. This acquisition helped expand the company’s offerings in the hollow fiber filtration market.
• In 2020, Repligen Corporation (US) acquired Engineered Molding Technology. This acquisition expanded Repligen’s line of single-use filtration products and gave the company more flexibility to scale and expand its single-use systems portfolio in the hollow fiber filtration market.
• In 2020 Danaher (US) acquired the Biopharma business from GE Company’s Life Sciences division. This business is known as Cytiva and acts as a standalone operating company within Danaher’s Life Sciences segment. This acquisition strengthened Danaher’s position in the hollow fiber filtration market.

Request for Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039

Top Key Players:

Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market.

The hollow fiber filtration market is expected to continue evolving, driven by advancements in technology, changes in industry regulations, and the increasing need for efficient and sustainable filtration solutions. To obtain the most current and detailed information about the market, it is advisable to consult industry reports, market analysts, and industry experts.

 

Revolutionizing Healthcare Data Management: Patient Registry Software

 The use of cloud-based patient registry solutions helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease. In addition, these solutions do not require any upfront capital investment for hardware and provide faster data transfer between organizations. Considering these advantages, the preference for cloud-based patient registry solutions is expected to increase among end users during the forecast period.

The global Patient registry software market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594  

Key Market Dynamics

1.DRIVERS
                   1.1 Government initiatives to build patient registries
                   1.2 Rising pressure to improve quality of care and reduce healthcare costs
                   1.3 Rising adoption of EHRs and other eHealth solutions
                   1.4 Growing patient volume due to global outbreak of COVID-19
                   1.5 Growing use of patient registry data for post-marketing surveillance

2. RESTRAINTS
                   2.1 Privacy- and data security-related concerns
                   2.2 Shortage of trained and skilled resources

3. OPPORTUNITIES
                   3.1 Rising number of accountable care organizations
                   3.2 Emergence of cloud-based patient registry solutions
                   3.3 High adoption rate of subscription model

4. CHALLENGES
                   4.1 Lack of interoperability and integration
                   4.2 Reluctance to adopt advanced solutions
                   4.3 Lack of awareness.

Market Segmentation:

On the basis of type of registry, the disease registries segment accounted for the largest share of the patient registry software market in 2020. The large share of this segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe.

Based on end user, the hospitals & medical practices segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are growing prevalence of research, QM and improvement, facility planning and marketing, and monitoring patient outcomes.

Regional Analysis:

Growth of the patient registry software market in the Asia Pacific region is mainly driven by the increasing incidence of chronic diseases, rising awareness about the benefits of EHRs, improvements in healthcare systems, the development of medical tourism in Asian countries, and high demand for EHRs in Asian countries. The adoption of innovative technologies is increasing in Asia Pacific. In this region, disease registries are a prime focus area, while medical devices and other product registries are comparatively underdeveloped. The region shows a very high demand for EHRs due to its rising geriatric population and prevalence of chronic conditions.

Inquiry Before Buying : https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144694594

Recent Developments of Patient Registry Software Industry

·         In March 2021, ESO Solutions (US) entered into a partnership with Virginia EMS Systems (US) to deliver a statewide EMS data repository and statewide trauma registry for the collection and analysis of data to reveal key insights and trends.

·         In December 2020, ImageTrend, Inc. (US) announced the latest National Trauma Data Bank (NTDB) Data Dictionary will be available in Patient Registry on January 1, 2021.

·         In November 2020, ArborMetrix, Inc. (US) entered into a partnership with the American Academy of Pediatrics to develop and grow a clinical registry to advance all children's health, well-being, and development.

Top Key Players:

Some of the prominent players in this patient registry software market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend, Inc. (US), Evado Clinical (Australia), WIRB Copernicus Group (US), Global Vision Technologies, Inc. (India), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), LUMEDX (US), Armus Corp (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data, Inc. (US).

In conclusion, the emergence of cloud-based patient registry solutions has revolutionized how healthcare organizations manage patient data and conduct medical research. The benefits of scalability, cost-efficiency, accessibility, security, and data analytics make cloud-based solutions an attractive option for organizations aiming to streamline their patient registry operations and accelerate research efforts. However, careful consideration of data privacy, migration strategies, provider reliability, and customization needs is essential when adopting such solutions.

Understanding Ventilators: A Comprehensive Market Analysis

 As per the recently published report by MarketsandMarkets™, The report "Ventilators Market by Mobility (ICU, Portable), Type (Adult/Paediatric, Neonatal), Mode, Interface (Invasive, Non-invasive), End User (Hospital,Clinic, ACC, Homecare), Key Stakeholder & Buying Criteria, Unmet Need, Reimbursement - Global Forecast to 2028", is projected to reach USD 5.7 billion in 2028 from USD 4.2 billion in 2023, at a CAGR of 6.4% during the forecast period.

 
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337
 
Browse

• 259     Market Data Tables
• 57       Figures
• 290     Pages and in-depth TOC on " Ventilators Market - Global Forecast to 2028”

Some of the prominent key players are:

• ResMed (US),
• Medtronic (Ireland),
• Vyaire Medical, Inc. (US),
• Getinge AB (Sweden),
• Drägerwerk AG & CO. KGAA (Germany),
• ICU Medical, Inc. (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the ventilator market.

• In 2022, the intensive care ventilators segment holds the largest share of the ventilators market. The growth of the intensive care ventilators segment is due to the susceptibility of geriatric individuals to develop severe health problems, the volume of patients being treated in critical care units is increasing, which in turn is driving the demand for intensive care beds.
• In 2022, the adult/pediatric ventilators segment accounted of the ventilators market. The large share of the adult/pediatric ventilators segment can be attributed to chronic diseases such as COPD & asthma, growing tobacco consumption, and the increasing geriatric population.
• In 2021, the hospitals and clinics segment accounted of the ventilators market. The hospitals and clinics segment will continue to dominate the market during the forecast period. 
• The APAC market is expected to grow at the highest rate during the forecast period, the growing prevalence of lifestyle related diseases such as obesity, a decreasing mortality rate, and the rising demand for home healthcare, are also driving the demand for ventilators.

 

In recent years, the the global market has evolved significantly due to technological advancements, such as the development of advanced portable ventilators and improvements in the sensor technologies used in ventilators. The demand for multimodal ventilators has been on the rise due to their versatility and ability to cater to a wide range of patients’ needs within a single device. These ventilators offer various ventilation modes and settings, making them suitable for treating patients with diverse respiratory conditions, from mild to severe. Particularly, during the COVID-19 pandemic, the flexibility of multimodal ventilators became essential in adapting to rapidly changing patient requirements, allowing healthcare providers to transition between modes seamlessly as patient conditions evolved. 

A Comprehensive Guide to High-Throughput Screening for Drug Discovery

 The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.6% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus on personalized medicine, technological advancements, and collaborative research efforts.

The report High-Throughput Screening (HTS) Market  is projected to reach USD 44.5 billion by 2028 from USD 25.7 billion in 2023, at a CAGR of 11.6% during the forecast period of 2023 to 2028.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Key Market Drivers: -

 

                   1.1 Growing adoption of open innovation models in pharmaceutical & biotechnology companies

                   1.2 Government funding and venture capital investments

                   1.3 Increasing R&D spending

                   1.4 Technological advancements

 

Market Segmentation: -

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables, instruments, services, and software. In 2022, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

Based on application, the high-throughput screening market is categorized into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2022. The key factor driving this segment's growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Regional Analysis: -

Geographically, the high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2022, North America accounted for the largest share of the high-throughput screening market, followed by Europe and Asia Pacific. The large share of North America in the global market is attributed to the increasing prevalence of diseases, rising pharmaceutical R&D expenditure, and the presence of major players in the region are factors driving the growth of the HTS market in this region.

Market Opportunity: -

Emerging markets like China, India, and Brazil have experienced rapid expansion in the life science and biotechnology sectors in recent years. These regions have a significant pool of talented researchers, physicians, and scientists who are actively pursuing research in these fields. Additionally, government initiatives in emerging markets play a crucial role in promoting the adoption and development of HTS technologies. Governments can establish regulatory frameworks and guidelines to ensure the safe and ethical use of HTS technologies.

Recent Developments of High Throughput Screening Industry

• In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler that integrates with the Agilent Bravo NGS automated liquid handling platform.
• In February 2023, PerkinElmer Inc. launched the Multimode Plate Reader for high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top Key Players: -

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).

            

Animal Growth Promoters and Performance Enhancers Market: Rise in the global demand for naturally produced growth promoters

 Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, helps to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period.

The global Animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167

MARKET DYNAMICS

           1 DRIVERS
                    1.1 Increase in demand and consumption of livestock-based products
                    1.2 Research for alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
                    1.3 Rise in the global demand for naturally produced growth promoters
                    1.4 Rise in awareness about growth promoters
                    1.5 Rise in animal epidemics and climate change

           2 RESTRAINTS
                    2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
                    2.2 Ban on antibiotics in different nations

           3 OPPORTUNITIES
                   3.1 Focus on increasing environmental sustainability

          4 CHALLENGES
                    4.1 Increasing global feed tonnage and high feed costs leading to the adoption of conventional feeding systems
                    4.2 Growing threat of disease transmission to and from agricultural animals

Market Segmentation: -

The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.

The poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.

Regional Analysis: -

Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=137134167

Top Key Players: -

Prominent players in the Animal Growth Promoters and Performance Enhancers Market include are Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd. (South Africa) and Novus International, Inc. (US).

 

Respiratory Diagnostics Market worth $8.2 billion by 2029 - Exclusive Report by MarketsandMarkets™

 As per the recently published report by MarketsandMarket™, The report "Respiratory Diagnostics Market by Product & Services (Devices, Reagents, Software), Test (PFT, Peak Flow, Spirometry), OSA, Imaging (X-ray, CT, MRI, PET), Molecular (PCR, DNA Sequencing), Indication (Lung Cancer, Asthma, COPD, TB) - Global Forecast to 2029".

The report Respiratory Diagnostics Market is expected to reach USD 8.2 billion by 2029 from USD 5.6 billion in 2023, at a CAGR of 6.6%, during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459
 
Browse

• 83       Market Data Tables
• 45       Figures
• 146     Pages and in-depth TOC on "Respiratory Diagnostics Market - Global Forecast to 2029”

Some of the prominent key players are:

• Koninklijke Philips N.V. (Netherlands),
• BD (US),
• Abbott (US),
• Thermo Fisher Scientific Inc. (US),
• GE HealthCare (US),
• Bio-Rad Laboratories, Inc. (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Respiratory Diagnostics Market.

• The growing trend towards point-of-care testing (POCT) represents a paradigm shift in healthcare, significantly contributing to the growth of the instruments and devices segment. Portable respiratory diagnostic instruments, such as handheld spirometers, peak flow meters, and portable imaging devices, enable real-time assessment of lung function and conditions.
• The escalating prevalence of respiratory disorders, particularly chronic obstructive pulmonary disease (COPD) and asthma, underscores the critical role of mechanical tests in assessing lung function. Mechanical tests, such as spirometry and peak flow tests, play a fundamental role in evaluating lung function by measuring parameters like airflow, lung volume, and capacity.
• Personalized asthma care is increasingly reliant on sophisticated diagnostic tools that consider individual patient profiles. Advanced diagnostics, such as molecular testing and biomarker analysis, enable healthcare professionals to delve into the specific genetic and molecular factors contributing to a patient's asthma.
• Hospitals and clinics are increasingly integrating respiratory diagnostics into routine care protocols. The seamless integration of respiratory diagnostics within hospitals and clinics ensures that diagnostic services are readily accessible to a broad spectrum of patients seeking routine or specialized care.
• In 2022, North America held the largest market share for respiratory diagnostics market. The growing awareness of the significance of early detection and effective management of respiratory diseases has emerged as a significant factor propelling the utilization of respiratory diagnostics products and services in North America.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=163390459

 

Growth in this market is largely driven by the growth in the large patient population suffering from pulmonary diseases, increase in pre-term deliveries, rise in adults being exposed to poor air quality index environment, increased smoking of tobacco, increased cases of passive smoking due to exposure to harmful smoke inhalations, rise in dust and allergies associated with it leading to asthma and COPD, rising R&D expenditure by leaders in this market, increased trend of smoking in women more than men, and massive rise in underlying lung diseases, and continuous exposre to indoor or outdoor dust, making it prone to infections, leading the market growth.